98%
921
2 minutes
20
Current guidance on the microbiological qualification testing of preservative-free multidose ophthalmic systems is limited and lacking in detail with respect to methodology. This study describes the testing performed to assess the potential for biofilm formation on the tip of a preservative-free multidose device and the microbiological quality of the delivered dose following a mixed culture microbial immersion challenge, simulating a severe, repeated microbial exposure event. Biofilm was assayed quantitatively through viable microbial recovery, semi-quantitatively by staining the biomass in conjunction with ImageJ analysis, and qualitatively by microscopy. The study demonstrated the utility of the immersion challenge as a relevant means of modeling biofilm growth on the preservative-free multidose device nozzle as well as the capability to reliably assess biofilm through a variety of measurements. The study further demonstrated the efficacy of the liner cap as a means of maintaining the microbiological quality of the delivered dose and significantly mitigating biofilm formation following a series of severe microbial immersion challenges.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5731/pdajpst.2025-000018.1 | DOI Listing |
PDA J Pharm Sci Technol
August 2025
Bausch + Lomb, 1400 N. Goodman St. Rochester, NY 14609 USA
Current guidance on the microbiological qualification testing of preservative-free multidose ophthalmic systems is limited and lacking in detail with respect to methodology. This study describes the testing performed to assess the potential for biofilm formation on the tip of a preservative-free multidose device and the microbiological quality of the delivered dose following a mixed culture microbial immersion challenge, simulating a severe, repeated microbial exposure event. Biofilm was assayed quantitatively through viable microbial recovery, semi-quantitatively by staining the biomass in conjunction with ImageJ analysis, and qualitatively by microscopy.
View Article and Find Full Text PDFClin Ophthalmol
August 2025
Sengi, Penniac, NB, Canada.
Purpose: To compare dry eye symptoms using the SANDE questionnaire as well as corneal and conjunctival staining with two propylene glycol lubricating eyedrops that contain very different excipients.
Methods: This was a single site, prospective, double-masked, randomized-controlled study with two arms comparing Systane Complete Multi-Dose Preservative Free (MDPF) eyedrops (Systane group) and Walgreen's Lubricant Balance eyedrops (WLB group). Participants were 18-65 years of age, had a total score of 20-55 inclusive on the Symptom Assessment iN Dry Eye (SANDE) questionnaire at the screening visit, and were not current contact lens wearers.
J Ocul Pharmacol Ther
July 2025
Department of Ophthalmology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkiye.
This study investigated the bacterial and fungal contamination of preservative-free, multidose cyclosporine (PFMD-Cyc) bottles. One hundred PFMD-Cyc eye drops administered by different patients for a minimum of 3 weeks were analyzed. The caps and first and second drops from the bottles underwent microbiological testing using sheep blood agar, chocolate agar, Sabouraud dextrose agar, and broth media.
View Article and Find Full Text PDFVaccines (Basel)
April 2025
Drug Safety Research and Development, Pfizer Worldwide Research, Development & Medical, Pfizer, Inc., Pearl River, NY 10965, USA.
Background: 2-Phenoxyethanol (2-PE) has been safely included as a preservative and/or stabilizer in more than thirty vaccine formulations at amounts ranging from 0.5 to 5 mg per dose; however, the nonclinical safety data publicly available for intramuscular (IM) or subcutaneous (SC) administration are relatively limited. Here, in addition to the available clinical and nonclinical data for 2-PE, we summarize the nonclinical safety data of experimental 13vPnC (Prev(e)nar 13) formulations with or without 2-PE.
View Article and Find Full Text PDFPLoS One
May 2025
Centre for Eye and Vision Research (CEVR), Shatin, Hong Kong SAR, China.
Background: Dry eye disease (DED) is a complex ocular disorder with a significant prevalence worldwide, especially in the Asian population. This study aimed to investigate changes in dry eye symptoms and signs following regular use of a new nanoemulsion eye drop, Systane COMPLETE Multi-Dose Preservative-Free (MDPF), in patients with mild to moderate DED in the Asian population.
Methods And Design: This is a prospective cohort study (ClinicalTrials.